comparemela.com

Page 9 - Mike Brophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Natera Announces Pricing of Follow-On Offering

/PRNewswire/ Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the pricing of its underwritten public offering.

New yorkUnited statesSan carlosCanaccord genuityLesley bogdanowMike brophyNatera incMorgan stanleyBroadridge financial solutionsExchange commission onStephens incExchange commissionProspectus departmentClinical laboratory improvement amendmentsCorporate communicationsSyndicate department

Natera Launches Proposed Follow-On Offering

/PRNewswire/ Natera, Inc. (Nasdaq: NTRA) ("Natera"), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public.

New yorkUnited statesSan carlosLesley bogdanowMike brophyNatera incMorgan stanleyBroadridge financial solutionsExchange commission onExchange commissionProspectus departmentClinical laboratory improvement amendmentsCorporate communicationsPrnewswire natera incSyndicate departmentMorgan stanley co

Natera Launches Proposed Follow-On Offering

/PRNewswire/ Natera, Inc. (Nasdaq: NTRA) ("Natera"), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public.

New yorkUnited statesSan carlosLesley bogdanowMike brophyNatera incMorgan stanleyBroadridge financial solutionsExchange commission onExchange commissionProspectus departmentClinical laboratory improvement amendmentsCorporate communicationsPrnewswire natera incSyndicate departmentMorgan stanley co

Natera Reports Third Quarter 2022 Financial Results

AUSTIN, Texas, Nov. 8, 2022 /PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial result.

United statesSan carlosMike brophySteve chapmanBrian symmonsNatera incCompany annual report on formClinical laboratory improvement amendmentsPrnewswire natera incUs department of veterans affairsCorporate affairsNature medicineKidney testChief executiveQuarter ended septemberVolume summary

Natera Awarded National MRD Testing Contract by the U S Department of Veterans Affairs

/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it was awarded a nationwide contract,.

United statesSan carlosLesley bogdanowMike brophyNatera incClinical laboratory improvement amendmentsCorporate communicationsUs department of veterans affairsPrnewswire natera incNational precision oncology programVeterans affairsSolomon moshkevichBreakthrough device designationsClin cancer

vimarsana © 2020. All Rights Reserved.